A citation-based method for searching scientific literature


List of co-cited articles
516 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.
Liliana B Menalled, Andrea E Kudwa, Sam Miller, Jon Fitzpatrick, Judy Watson-Johnson, Nicole Keating, Melinda Ruiz, Richard Mushlin, William Alosio, Kristi McConnell,[...]. PLoS One 2012
235
45

Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.
Taneli Heikkinen, Kimmo Lehtimäki, Nina Vartiainen, Jukka Puoliväli, Susan J Hendricks, Jack R Glaser, Amyaouch Bradaia, Kristian Wadel, Chrystelle Touller, Outi Kontkanen,[...]. PLoS One 2012
148
40

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.
G J Klapstein, R S Fisher, H Zanjani, C Cepeda, E S Jokel, M F Chesselet, M S Levine. J Neurophysiol 2001
246
37

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
37


Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models.
Carlos Cepeda, Laurie Galvan, Sandra M Holley, Shilpa P Rao, Véronique M André, Elian P Botelho, Jane Y Chen, Joseph B Watson, Karl Deisseroth, Michael S Levine. J Neurosci 2013
80
34

Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.
Prasad R Joshi, Nan-Ping Wu, Véronique M André, Damian M Cummings, Carlos Cepeda, John A Joyce, Jeffrey B Carroll, Blair R Leavitt, Michael R Hayden, Michael S Levine,[...]. J Neurosci 2009
129
31

Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.
Carlos Cepeda, Raymond S Hurst, Christopher R Calvert, Elizabeth Hernández-Echeagaray, Oanh K Nguyen, Emily Jocoy, Lindsey J Christian, Marjorie A Ariano, Michael S Levine. J Neurosci 2003
253
28

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Michelle Gray, Dyna I Shirasaki, Carlos Cepeda, Véronique M André, Brian Wilburn, Xiao-Hong Lu, Jifang Tao, Irene Yamazaki, Shi-Hua Li, Yi E Sun,[...]. J Neurosci 2008
443
28

The corticostriatal pathway in Huntington's disease.
Carlos Cepeda, Nanping Wu, Véronique M André, Damian M Cummings, Michael S Levine. Prog Neurobiol 2007
232
28


Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice.
Xiaoping Tong, Yan Ao, Guido C Faas, Sinifunanya E Nwaobi, Ji Xu, Martin D Haustein, Mark A Anderson, Istvan Mody, Michelle L Olsen, Michael V Sofroniew,[...]. Nat Neurosci 2014
337
28

Differential loss of striatal projection neurons in Huntington disease.
A Reiner, R L Albin, K D Anderson, C J D'Amato, J B Penney, A B Young. Proc Natl Acad Sci U S A 1988
740
25

Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF.
Carlos Cepeda, Amaal J Starling, Nanping Wu, Oanh K Nguyen, Besim Uzgil, Takahiro Soda, Veronique M André, Marjorie A Ariano, Michael S Levine. J Neurosci Res 2004
102
25

Differential electrophysiological changes in striatal output neurons in Huntington's disease.
Véronique M André, Carlos Cepeda, Yvette E Fisher, My Huynh, Nora Bardakjian, Sumedha Singh, X William Yang, Michael S Levine. J Neurosci 2011
96
25

Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse.
B R Miller, J L Dorner, M Shou, Y Sari, S J Barton, D R Sengelaub, R T Kennedy, G V Rebec. Neuroscience 2008
211
25

Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
Liliana B Menalled, Jessica D Sison, Ioannis Dragatsis, Scott Zeitlin, Marie-Françoise Chesselet. J Comp Neurol 2003
337
25

Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.
L A Raymond, V M André, C Cepeda, C M Gladding, A J Milnerwood, M S Levine. Neuroscience 2011
200
22


Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, Sarah H Coleman, Rona K Graham, Yu Deng, Rosemary Oh, Nagat Bissada, Sazzad M Hossain, Yu-Zhou Yang,[...]. Hum Mol Genet 2003
587
22

Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease.
Joshua L Plotkin, Michelle Day, Jayms D Peterson, Zhong Xie, Geraldine J Kress, Igor Rafalovich, Jyothisri Kondapalli, Tracy S Gertler, Marc Flajolet, Paul Greengard,[...]. Neuron 2014
122
22


Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.
Damian M Cummings, Véronique M André, Besim O Uzgil, Steven M Gee, Yvette E Fisher, Carlos Cepeda, Michael S Levine. J Neurosci 2009
120
20

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.
J G Hodgson, N Agopyan, C A Gutekunst, B R Leavitt, F LePiane, R Singaraja, D J Smith, N Bissada, K McCutcheon, J Nasir,[...]. Neuron 1999
635
20

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
20

Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect.
Michael S Levine, Carlos Cepeda, Miriam A Hickey, Sheila M Fleming, Marie-Françoise Chesselet. Trends Neurosci 2004
127
20

In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects.
Mathilde Faideau, Jinho Kim, Kerry Cormier, Richard Gilmore, Mackenzie Welch, Gwennaelle Auregan, Noelle Dufour, Martine Guillermier, Emmanuel Brouillet, Philippe Hantraye,[...]. Hum Mol Genet 2010
194
20


Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation.
P F Behrens, P Franz, B Woodman, K S Lindenberg, G B Landwehrmeyer. Brain 2002
232
20

Impaired glutamate uptake in the R6 Huntington's disease transgenic mice.
J C Liévens, B Woodman, A Mahal, O Spasic-Boscovic, D Samuel, L Kerkerian-Le Goff, G P Bates. Neurobiol Dis 2001
217
20

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
20

Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling.
Csaba Földy, Robert C Malenka, Thomas C Südhof. Neuron 2013
180
20

Striatal potassium channel dysfunction in Huntington's disease transgenic mice.
Marjorie A Ariano, Carlos Cepeda, Christopher R Calvert, Jorge Flores-Hernández, Elizabeth Hernández-Echeagaray, Gloria J Klapstein, Scott H Chandler, Neil Aronin, Marian DiFiglia, Michael S Levine. J Neurophysiol 2005
82
20

Corticostriatal synaptic adaptations in Huntington's disease.
Joshua L Plotkin, D James Surmeier. Curr Opin Neurobiol 2015
70
20


Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.
G A Laforet, E Sapp, K Chase, C McIntyre, F M Boyce, M Campbell, B A Cadigan, L Warzecki, D A Tagle, P H Reddy,[...]. J Neurosci 2001
204
17

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
933
17



Reduced tonic inhibition in striatal output neurons from Huntington mice due to loss of astrocytic GABA release through GAT-3.
Anna M Wójtowicz, Anton Dvorzhak, Marcus Semtner, Rosemarie Grantyn. Front Neural Circuits 2013
59
17

The functional anatomy of basal ganglia disorders.
R L Albin, A B Young, J B Penney. Trends Neurosci 1989
17

Endocannabinoid signaling and synaptic function.
Pablo E Castillo, Thomas J Younts, Andrés E Chávez, Yuki Hashimotodani. Neuron 2012
554
17


Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms.
Carlos Cepeda, Damian M Cummings, Véronique M André, Sandra M Holley, Michael S Levine. ASN Neuro 2010
61
17

Dysfunctional Calcium and Glutamate Signaling in Striatal Astrocytes from Huntington's Disease Model Mice.
Ruotian Jiang, Blanca Diaz-Castro, Loren L Looger, Baljit S Khakh. J Neurosci 2016
115
17

Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease.
Rona K Graham, Mahmoud A Pouladi, Prasad Joshi, Ge Lu, Yu Deng, Nan-Ping Wu, Bryan E Figueroa, Martina Metzler, Véronique M André, Elizabeth J Slow,[...]. J Neurosci 2009
94
14

GABAergic microcircuits in the neostriatum.
James M Tepper, Tibor Koós, Charles J Wilson. Trends Neurosci 2004
292
14

Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice.
Diego Centonze, Silvia Rossi, Chiara Prosperetti, Anne Tscherter, Giorgio Bernardi, Mauro Maccarrone, Paolo Calabresi. Biol Psychiatry 2005
63
14

Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's Disease.
Véronique M André, Yvette E Fisher, Michael S Levine. Front Syst Neurosci 2011
58
14

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.
Véronique M André, Carlos Cepeda, Angela Venegas, Yeranui Gomez, Michael S Levine. J Neurophysiol 2006
54
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.